Related Experiment Video

Updated: Jul 25, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Design of the Trial of Org 10172 in Acute Stroke Treatment (TOAST)

H P Adams1, R F Woolson, W R Clarke

  • 1Department of Neurology, University of Iowa College of Medicine, Iowa City 52242, USA.

Controlled Clinical Trials
|August 1, 1997
PubMed

Insights

The Treatment of Acute Ischemic Stroke (TOAST) trial evaluated a new antithrombotic drug for acute ischemic stroke. This study focused on improving trial design to accurately assess treatment efficacy in stroke patients.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Clinical Trials

Background:

  • Acute ischemic stroke treatment efficacy has historically lacked robust clinical trial evidence.
  • Previous clinical trial designs may have contributed to inconclusive results in stroke treatment research.
  • Identifying effective antithrombotic therapies remains a critical unmet need for stroke patients.

Purpose of the Study:

  • To assess the efficacy of a novel antithrombotic agent in improving outcomes for patients with acute ischemic stroke.
  • To address and overcome design limitations identified in prior stroke clinical trials.
  • To report on the strategic approaches employed in the design, implementation, and coordination of the TOAST trial.

Main Methods:

  • A multicenter, randomized, placebo-controlled clinical trial design was utilized.
  • The trial specifically focused on individuals experiencing acute ischemic stroke.
  • Key strategies were implemented to ensure accurate testing of the antithrombotic treatment's usefulness.

Main Results:

  • The TOAST trial was designed to rigorously evaluate a new antithrombotic drug.
  • Methodological improvements were incorporated to enhance the accuracy of treatment effect assessment.
  • The trial's design aimed to provide definitive evidence on the drug's impact on stroke outcomes.

Conclusions:

  • The TOAST trial employed robust design strategies to accurately test a new antithrombotic drug for acute ischemic stroke.
  • Addressing previous trial design flaws was central to the TOAST study methodology.
  • The reported strategies aim to improve the reliability of future clinical trial outcomes in stroke research.

More Related Videos

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke08:53

Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke

Published on: June 6, 2025

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo06:38

The Stroke Preclinical Assessment Network Multi-Laboratory Model of Thromboembolic Stroke with Thrombolysis: TE-MCAo

Published on: December 19, 2025

Related Concept Videos

Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...